[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2020903103A0 - Cannabinoid Formulations and Methods of Use - Google Patents

Cannabinoid Formulations and Methods of Use

Info

Publication number
AU2020903103A0
AU2020903103A0 AU2020903103A AU2020903103A AU2020903103A0 AU 2020903103 A0 AU2020903103 A0 AU 2020903103A0 AU 2020903103 A AU2020903103 A AU 2020903103A AU 2020903103 A AU2020903103 A AU 2020903103A AU 2020903103 A0 AU2020903103 A0 AU 2020903103A0
Authority
AU
Australia
Prior art keywords
methods
cannabinoid formulations
cannabinoid
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020903103A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Preveceutical Medical Inc
Original Assignee
Preveceutical Medical Inc
Filing date
Publication date
Application filed by Preveceutical Medical Inc filed Critical Preveceutical Medical Inc
Publication of AU2020903103A0 publication Critical patent/AU2020903103A0/en
Priority to PCT/IB2021/022211 priority Critical patent/WO2022043759A1/en
Priority to CA3193462A priority patent/CA3193462A1/en
Priority to US18/043,398 priority patent/US20230346808A1/en
Priority to AU2021330383A priority patent/AU2021330383A1/en
Priority to EP21860630.9A priority patent/EP4203946A4/en
Abandoned legal-status Critical Current

Links

AU2020903103A 2020-08-31 2020-08-31 Cannabinoid Formulations and Methods of Use Abandoned AU2020903103A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/IB2021/022211 WO2022043759A1 (en) 2020-08-31 2021-08-31 Cannabinoid formulations and methods of use
CA3193462A CA3193462A1 (en) 2020-08-31 2021-08-31 Cannabinoid formulations and methods of use
US18/043,398 US20230346808A1 (en) 2020-08-31 2021-08-31 Cannabinoid formulations and methods of use
AU2021330383A AU2021330383A1 (en) 2020-08-31 2021-08-31 Cannabinoid formulations and methods of use
EP21860630.9A EP4203946A4 (en) 2020-08-31 2021-08-31 Cannabinoid formulations and methods of use

Publications (1)

Publication Number Publication Date
AU2020903103A0 true AU2020903103A0 (en) 2020-09-17

Family

ID=

Similar Documents

Publication Publication Date Title
EP3962296A4 (en) Cannabinoid compositions and methods of using
EP3997115A4 (en) Il-2 compositions and methods of use thereof
EP3976638A4 (en) Il-2 compositions and methods of use thereof
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
EP4072576A4 (en) Il-2 orthologs and methods of use
EP4076487A4 (en) Emulsifying formulations of cannabinoids and/or cannabinoid extracts
EP4103662A4 (en) Polishing compositions and methods of use thereof
EP4125831A4 (en) Kcnt1 inhibitors and methods of use
EP4010024A4 (en) Oral formulations of cannabis extracts and methods of making same
EP4127088A4 (en) Polishing compositions and methods of use thereof
EP3952721A4 (en) Endoscope and method of use
EP4106870A4 (en) Compositions and therapeutic uses of cannabidiol
EP4048298A4 (en) Preparation and use of therapeutic hydrogels
EP4110066A4 (en) Formulations and uses thereof
EP4037715A4 (en) Protein-macromolecule conjugates and methods of use thereof
EP4103663A4 (en) Polishing compositions and methods of use thereof
EP4142740A4 (en) Compositions and methods of use thereof
EP4090383A4 (en) Il2 orthologs and methods of use
EP3897684A4 (en) Cannabinoid formulations and methods of making same
EP3969460A4 (en) Ascaroside derivatives and methods of use
EP3911415A4 (en) Dapsone formulations and methods of using same
EP4054549A4 (en) Topical formulations of cyclooxygenase inhibitors and their use
EP4110317A4 (en) Kcnt1 inhibitors and methods of use
EP4203946A4 (en) Cannabinoid formulations and methods of use
EP3968872A4 (en) Surgical tools and methods of use